This is the most amazing little stock. The company has a tiger by the tail. It has been green lighted for Phase III Clinical Trials for their kidney (more specifically Lupus Nephritis) drug Voclosporin which has, so far, demonstrated complete remission in an amazing percentages of cases.
The stock has been wrongfully punished due to some predictable deaths in phase II trials. Surprise, kidney disease kills people... ಠ_ಠ ...
At any rate, the stock is at a waaaaay undervalued 2.90 ... Check it out.
Submitted November 29, 2016 at 01:57PM by irritatedrhino http://ift.tt/2fzdOSD
No comments:
Post a Comment